C–C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is characterised by accelerated lipid deposition, aberrant inflammation, and excessive extracellular matrix production in the liver. Short of effective intervention, NAFLD can progress to cirrhosis and hepatocellular carcinoma. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Zhiwen, Sun, Xinyue, Chen, Xuelian, Liu, Huimin, Miao, Xiulian, Guo, Yan, Xu, Yong, Li, Jie, Zou, Xiaoping, Li, Zilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404559/
https://www.ncbi.nlm.nih.gov/pubmed/37555008
http://dx.doi.org/10.1016/j.jhepr.2023.100805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404559/
https://www.ncbi.nlm.nih.gov/pubmed/37555008
http://dx.doi.org/10.1016/j.jhepr.2023.100805

Ejemplares similares